1. Short title This Act may be cited as the Restoring Normalcy in America Act . 2. HHS COVID–19 study (a) In general The Secretary of Health and Human Services shall conduct a study on— (1) the effectiveness of vaccines licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ) or authorized for emergency use under section 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–3 ) in providing immunization against COVID–19 (including any additional doses of such a vaccine to be administered after the primary series of doses); (2) the effectiveness of treatments approved under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ), licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ), or authorized for emergency use under section 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–3 ) to treat COVID–19; (3) the rate of transmission of SARS–CoV–2 throughout the United States, beginning on the first day of the emergency period (as defined in section 1135(g)(1)(B) of the Social Security Act ( 42 U.S.C. 1320b–5(g)(1)(B) )); (4) the level of preparedness of the United States for future pandemics